Genomics company Pacific Biosciences of California (NASDAQ:PACB) announced better-than-expected revenue in Q1 CY2025, but ...

PACB benefits from strong first-quarter results, product innovation, and cost cuts to offset sales cycle delays and drive 2025 growth.

A research team has identified two novel genetic mechanisms for disease resistance in wheat, offering promising strategies to ...

The global genomics market, valued at US$42.4 billion in 2023, stood at US$42.6 billion in 2024 and is projected to advance ...

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Run out of room in your tax-sheltered investment accounts? Here's how you can position the rest of your portfolio. Analysts recommend these stocks, which range from consumer-product companies to ...

Famed for its deep purple berries and potent antioxidant properties, black wolfberry (Lycium ruthenicum) thrives in harsh ...